ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,038.53
      1.08%
      US Tech 100
      21,206.40
      0.04%
      Dow Jones
      43,315.78
      0.04%
      Brent Oil
      73.11
      -0.24%
      Bitcoin
      95,713.42
      -3.61%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Nuvectis Pharma Inc (NVCT)

      7. Nuvectis Pharma Inc (NVCT) News

      Nuvectis Pharma Inc

      Nuvectis Pharma Inc (NVCT)

      NASDAQ
      4.7737
      0.1237
      ( 2.66% )
      Updated: 13:22:20
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      NVCT News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 20 2024
      NVCT (2.66%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 08 2024
      NVCT (2.66%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 05 2024
      NVCT (2.66%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 05 2024
      NVCT (2.66%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 29 2024
      NVCT (2.66%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 06 2024
      NVCT (2.66%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 06 2024
      NVCT (2.66%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 13 2024
      NVCT (2.66%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 13 2024
      NVCT (2.66%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 13 2024
      NVCT (2.66%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 13 2024
      NVCT (2.66%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 07 2024
      NVCT (2.66%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 07 2024
      NVCT (2.66%)

      NVCT Discussion

      View Posts
      gail gail 1 month ago
      grabbed some on the dip
      👍️0
      Monksdream Monksdream 4 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 6 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 8 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 10 months ago
      NVCT 10Q due March 6
      👍️0
      Monksdream Monksdream 12 months ago
      NVCT a bounce
      👍️0
      conix conix 3 years ago
      NVCT HIGHLIGHTS:

      *Recently completed Initial Public Offering - $5.00 Per share
      *2 Precision Cancer medicines in development - ovarian and triple negative breast
      *Data flow throughout 2022
      *CEO with multiple success stories in life science sector to $billion dollar market caps
      *Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

      Nuvectis Pharma Inc - Company Background:

      Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

      Market Capitalization: $225 million
      Range - 52 week: $3.08 - $20.75
      Current Price: $20.44
      Trades on: Nasdaq Capital Market
      Ticker Symbol: NVCT

      website: nuvectis.com
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      wow from $3 to almost $21
      👍️0
      ipo_dude ipo_dude 3 years ago
      $27 we come
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      WOW $7 MOVE 3-10


      CONGRAT$ NVCT
      👍️0
      spindog spindog 3 years ago
      I feel the same
      👍️0
      kkballa kkballa 3 years ago
      hmmm.
      👍️0

      Your Recent History

      NASDAQ
      NVCT
      Nuvectis Pharma
      NEO
      EPCH
      Emerge Empwr Sustainable...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads